Meeting to be held on May 23 hosted by Piper Sandler.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LENZ:
- Lenz Therapeutics’ Growth at Risk Amid IP Licensing Battles in Competitive Pharma Landscape
- Lenz Therapeutics reports Q1 EPS ($3.53), consensus (84c)
- LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
- LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024
- William Blair starts Lenz at Outperform, expects strategic interest
Questions or Comments about the article? Write to editor@tipranks.com